Comparative study on anti-proliferative potentials of zinc oxide and aluminium oxide nanoparticles in colon cancer cells.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
23 05 2019
Historique:
received: 27 11 2017
accepted: 02 02 2018
entrez: 25 5 2019
pubmed: 28 5 2019
medline: 25 2 2020
Statut: epublish

Résumé

Use of commercial products containing nanoparticles formulated from zinc oxide (ZnO) and aluminium oxide (Al2O-3) has increased significantly. These nanoparticles are widely used as ingredient in cosmetics, and also in food packaging industry although their toxicity status is yet to be studied. Here, we aimed to explore the effect of zinc oxide nanoparticles (ZnO-NPs) and aluminium oxide nanoparticles (ANPs) in human HT29 colon cancer cell line. In this study, ZnO-NPs were synthesized by chemical method and ANPs synthesized by sol-gel method and were characterized using UV-Vis spectroscopy, X ray diffraction and Transmittance electron microscopy. The effects of ZnO-NPs and ANPs was determined by cell viability, membrane integrity and colony formation potentials. ZnO-NPs and ANPs inhibit HT29, colon cancer cell proliferation in a dose dependent manner, and affect the membrane potentials and also prevent the colony formation. The results suggest that ZnO NPs are found to be more effective than ANPs in reducing colon cancer cell proliferation.

Sections du résumé

BACKGROUND AND AIM OF THE STUDY
Use of commercial products containing nanoparticles formulated from zinc oxide (ZnO) and aluminium oxide (Al2O-3) has increased significantly. These nanoparticles are widely used as ingredient in cosmetics, and also in food packaging industry although their toxicity status is yet to be studied. Here, we aimed to explore the effect of zinc oxide nanoparticles (ZnO-NPs) and aluminium oxide nanoparticles (ANPs) in human HT29 colon cancer cell line.
METHODS
In this study, ZnO-NPs were synthesized by chemical method and ANPs synthesized by sol-gel method and were characterized using UV-Vis spectroscopy, X ray diffraction and Transmittance electron microscopy. The effects of ZnO-NPs and ANPs was determined by cell viability, membrane integrity and colony formation potentials.
RESULTS
ZnO-NPs and ANPs inhibit HT29, colon cancer cell proliferation in a dose dependent manner, and affect the membrane potentials and also prevent the colony formation.
CONCLUSIONS
The results suggest that ZnO NPs are found to be more effective than ANPs in reducing colon cancer cell proliferation.

Identifiants

pubmed: 31125002
doi: 10.23750/abm.v90i2.6939
pmc: PMC6776199
doi:

Substances chimiques

Aluminum Oxide LMI26O6933
Zinc Oxide SOI2LOH54Z

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-247

Références

Nanomaterials (Basel). 2015 Jun 09;5(2):1004-1021
pubmed: 28347048
Int J Nanomedicine. 2012;7:845-57
pubmed: 22393286
Methods Enzymol. 1978;52:302-10
pubmed: 672633
J Biomed Nanotechnol. 2013 Mar;9(3):441-9
pubmed: 23621000
Int J Nanomedicine. 2015 May 25;10:3751-60
pubmed: 26045665
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Drug Discov Today. 2017 Aug;22(8):1224-1232
pubmed: 28545838
Nanomedicine. 2011 Dec;7(6):904-13
pubmed: 21664489
Nanoscale Res Lett. 2012 Oct 30;7(1):602
pubmed: 23110934
Pharm Res. 2011 Feb;28(2):237-59
pubmed: 21104301
J Mater Sci Mater Med. 2009 Jan;20(1):11-22
pubmed: 18651111
Nanotechnology. 2008 Jul 23;19(29):295103
pubmed: 18836572

Auteurs

Vimala Devi Subramaniam (VD)

Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai-603103, India. vimaladevi17@gmail.com.

Murugesan Ramachandran (M)

Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai-603103, India. vimaladevi17@gmail.com.

Francesco Marotta (F)

ReGenera R&D International for Aging Intervention, Milan and Beijing, China-Italy

Antara Banerjee (A)

Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai-603103, India. vimaladevi17@gmail.com.

Xiao Feng Sun (XF)

Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

Surajit Pathak (S)

Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai-603103, India. vimaladevi17@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH